Back to funds
View filing
ACORN CAPITAL ADVISORS, LLC
hedge fundUpdated 28 days agoManaged by Acorn Capital Advisors, Llc • Latest filing Q2 2026
Portfolio value
$366.5M
Q2 2026
Filings
7
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 7 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2024 | $185M |
| Q1 2025 | $143.7M |
| Q2 2025 | $152.9M |
| Q3 2025 | $197M |
| Q4 2025 | $295.1M |
| Q1 2026 | $351.8M |
| Q2 2026 | $366.5M |
Top holdings
20 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | C CGON CG ONCOLOGY INC | $80.4M | 1.13M | 21.94% | — |
| 2 | U URGN UROGEN PHARMA LTD | $61.6M | 1.67M | 16.80% | — |
| 3 | T TRVI TREVI THERAPEUTICS INC | $40M | 2.14M | 10.92% | — |
| 4 | C CGC CANDEL THERAPEUTICS INC | $36M | 3.50M | 9.83% | — |
| 5 | ? N/A PUMA BIOTECHNOLOGY INC | $33.5M | 4.13M | 9.14% | — |
| 6 | J JBIO JADE BIOSCEINCES INC | $21.9M | 986.8K | 5.98% | — |
| 7 | B BCAX BICARA THERAPEUTICS | $19.1M | 643.4K | 5.21% | — |
| 8 | K KPTI KARYOPHARM THERAPEUTICS INC | $14.8M | 1.52M | 4.05% | — |
| 9 | O OKUR ONKURE THERAPEUTICS INC | $12.9M | 2.84M | 3.53% | — |
| 10 | H HELP HELUS PHARMA INC. | $10.2M | 1.54M | 2.78% | — |
| 11 | T TARA PROTARA THERAPEUTICS INC | $6.7M | 1.75M | 1.83% | — |
| 12 | A AURA AURA BIOSCIENCES INC | $6.6M | 929.1K | 1.80% | — |
| 13 | L LONA LEONABIO, INC. | $5.8M | 634.5K | 1.59% | — |
| 14 | V VSTM VERASTEM INC | $5.6M | 1.47M | 1.53% | — |
| 15 | ? N/A WHITEHAWK THERAPEUTICS INC | $5.2M | 1.14M | 1.42% | — |
| 16 | Q QTTB Q32 BIO INC. | $2.8M | 216.2K | 0.75% | — |
| 17 | E ENGNW EUGENE THERAPEUTICS | $2.2M | 1.27M | 0.60% | — |
| 18 | J JSPRW JASPER THERAPEUTICS | $604K | 1.44M | 0.16% | — |
| 19 | ? N/A BIOATLA INC | $448K | 108.1K | 0.12% | — |
| 20 | V VYNE VYNE THERAPEUTICS INC | $926 | 1.4K | 0.00% | — |